Separation and Identification of Tubocapsanolide MAP and Tubocapsunolide A, and the Structure-Activity Relationship of Their Anti-Tnbc Activity.

PanTing Shou,Jiao Li,YingYing Wei,GuoYin Kai,FuQian Wang,HuaJun Zhao,Bo Yang
DOI: https://doi.org/10.1016/j.steroids.2020.108734
IF: 2.76
2020-01-01
Steroids
Abstract:A new withanolide, tubocaapsanolide MAP (MeOH addition product) (1), as well as its known precursor tubocaapsanolide A (2) were obtained from Tubocapsicum anomalum (Solanaceae). Compound 1 was a MeOH addition product transformed from compound 2 during the process of separation using MeOH as solvent. The structures of the two withanolides including absolute configuration were elucidated by extensive spectroscopic analysis and X-ray single crystal diffraction. In the test of anti-triple negative breast cancer (TNBC) effects, tubocapsusanlide A (2) showed potent inhibitory activity against four human TNBC cell lines, while tubocapsusanlide MAP (1) exhited significantly weaker inhibitory than that of tubocapsusanlide A (2), indicating that α-β unsaturated carbonyl unit contained in 2 was closely related to its anti-TNBC activity. The potent bioactivity displayed significant developing potential of withanolides as anti-TNBC lead compounds or drug candidates. And this report may provide some useful guidances for the preparation and bioactivity research of withanolides.
What problem does this paper attempt to address?